Dr. Day is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 First St SW
Rochester, MN 55905- Is this information wrong?
Education & Training
- Mayo ClinicResidency, 2027
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2020 - 2024
- Southern Illinois University School of MedicineClass of 2020
- St. Louis College of PharmacyPharmD, Magna Cum Laude, 2008 - 2014
Certifications & Licensure
- MN State Medical License 2024 - 2025
- IA State Medical License 2020 - 2024
Awards, Honors, & Recognition
- François M. Abboud Resident Research Award University of Iowa Department of Internal Medicine, 2023
- Graduate Medical Education Excellence in Clinical Teaching Award University of Iowa GME, 2021-2023
Publications & Presentations
PubMed
- 16 citationsThe effect of APOE ε4 allele on cholinesterase inhibitors in patients with Alzheimer disease: evaluation of the feasibility of resting state functional connectivity ma...Liang Wang, Jonathan R Day, Catherine M. Roe, Matthew R. Brier, Jewell B. Thomas
Alzheimer Disease and Associated Disorders. 2014-04-01 - 12 citationsEpidemiology of Hospitalized Patients with Babesiosis, United States, 2010-2016.Evan M Bloch, Jonathan R Day, Peter J Krause, Anne Kjemtrup, Sheila F O'Brien
Emerging Infectious Diseases. 2022-02-01 - 1 citationsPatient reported quality of life in young adults with sarcoma receiving care at a sarcoma center.Jonathan R Day, Benjamin Miller, Bradley T Loeffler, Sarah L Mott, Munir Tanas
Frontiers in Psychology. 2022-01-01
Books/Book Chapters
Abstracts/Posters
- Outcomes and Prognostic Factors of Transformed Follicular Lymphoma: An Analysis from the LEO ConsortiumJonathan R Day, Melissa C. Larson, Carla Casulo, Yucai Wang, Dai Chihara, Brad S. Kahl, Peter Martin, Izidore S. Lossos, Victor M. Orellana-Noia, Richard Burack, Jonat..., ASH 2022, New Orleans, LA; Blood (2022) 140 (Supplement 1): 6642–6644., 12/10/2022
- Favorable Overall Survival Following First and Second Relapse of MCL with Availability of Novel Therapies: Results from the Lion Prospective Observational RegistryDavid A. Bond, Jason T. Romancik, Jeffrey M. Switchenko, Brielle Berkowitz, Jonathan R Day, Umar Farooq, Sabarish Ayyappan, Katelin Baird, Michelle L. Churchman, Andre..., ASH 2022;, Blood (2022) 140 (Supplement 1): 6509–6511., 12/10/2022
- Therapy for patients with POD24 follicular lymphoma: Treatment patterns and outcomes from the Lymphoma Epidemiology of Outcomes (LEO) Consortium.Casulo C, Larson MC, Day JR, Habermann TM, Lossos IS, Wang Y, Nastoupil LJ, Strouse C, Chihara D, Martin P, Cohen JB, Kahl BS, Burack WR, Koff JL, Friedberg JW, Cerhan..., Journal of Clinical Oncology / ASCO, Chicago, IL, 6/4/2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: